Jennifer A Philips

Title: Innovator Spotlight: Jennifer A. Philips

Introduction

Jennifer A. Philips is an accomplished inventor based in St. Louis, MO, whose groundbreaking work in microbiology has led to significant advancements in the fight against infectious diseases. She holds a patent focused on the innovative use of fatty acid oxidation inhibitors as antimicrobials, which underscores her contributions to medical research.

Latest Patents

Jennifer A. Philips is credited with one patent titled "Use of fatty acid oxidation inhibitors as antimicrobials." This patent details methods of using small molecule inhibitors of fatty acid oxidation (FAO) as effective antimicrobials against intracellular Mycobacteria. The FAO inhibitors mentioned in her research, including etomoxir, trimetazidine, oxfenicine, and perhexeline, can be utilized alone or in combination with known antimycobacterial agents, marking a notable advancement in treatment approaches for difficult-to-treat infections.

Career Highlights

Throughout her career, Jennifer has gained valuable experience by working with prestigious institutions, including Washington University and New York University. Her work in these environments has allowed her to collaborate on significant research and contribute to the scientific community.

Collaborations

Jennifer A. Philips has collaborated with several notable researchers, including Kathryn J. Moore and Pallavi Chandra. These collaborations have undoubtedly enriched her research and fostered an environment of innovation and discovery in microbial therapeutics.

Conclusion

As an inventor, Jennifer A. Philips stands out for her innovative contributions to the field of microbiology. Her patented work on fatty acid oxidation inhibitors showcases her commitment to improving antimicrobial therapies and highlights the importance of continued research in this vital area of health care.